CRP and susceptibility to pneumonia measurement: The use of biomarker tests, such as (procalcitonin) PCT or (c-reactive protein) CRP, for diagnosing and monitoring pneumonia has been suggested, although most studies have not been specifically conducted in immunocompromised individuals.